babyLance™ - MediPurpose
17876
page-template-default,page,page-id-17876,bridge-core-2.5.9,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-theme-ver-24.4,qode-theme-bridge,disabled_footer_top,qode-wpml-enabled,wpb-js-composer js-comp-ver-8.0.1,vc_responsive

babyLance™

SPECIAL NOTICE: babyLance™ has been acquired by Clinical Innovations, a medical device company focused in labor and delivery and the neonatal suite.

Case Study: How MediPurpose designed, developed and marketed the babyLance™ product line and finally sold it to Clinical Innovations in July 2016

Understanding the Needs of End-Users

Listening to End-Users: Heelstick Trigger Activation Survey at the 2011 NANN Conference

Translating User Requirements Into Design Specifications: Optimizing Ease-of-Activation

Heelstick Cut Profile Comparative Study

Listening to End-Users: Simulated Use Design Validation Study

Listening to End-Users: Clinical Use Design Validation Study

Defining, Translating and Validating Ergonomic Design Specifications

Obtaining a U.S. FDA 510(k) for Sharps Prevention Features

Defining, Translating and Validating Safety Features

A Summary of babyLance™ Features: Design and Validation

Safe in Common’s “10 Golden Rules”: How Does the babyLance™ Safety Heelstick Compare?